A prospective, multi-center, double-blind, randomized, placebo-controlled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all-cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by surgical clipping
01.09.2007
Aneurysmal subarachnoid hemorrhage has been designated as an orphan disease and remains an important cause of morbidity and mortality despite advances in medical and surgical therapy. One important complication of subarachnoid hemorrhage is cerebral...
Klinische Forschung -
01.09.2007 - 31.03.2010
Automatisch geschlossen
Projektleitung: Seule Martin, Hildebrandt Gerhard
Mitarbeiter/innen: Gautschi Oliver
Weiter
